JLGRX
Price
$91.73
Change
-$0.13 (-0.14%)
Updated
Sep 5 closing price
Net Assets
119.19B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

JLGRX vs RGEBX

Header iconJLGRX vs RGEBX Comparison
Open Charts JLGRX vs RGEBXBanner chart's image
JPMorgan Large Cap Growth R5
Price$91.73
Change-$0.13 (-0.14%)
VolumeN/A
Net Assets119.19B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
JLGRX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JLGRX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGRX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. JLGRX (119B). JLGRX pays higher dividends than RGEBX: JLGRX (0.10) vs RGEBX (0.00). JLGRX was incepted earlier than RGEBX: JLGRX (16 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than JLGRX (0.60). JLGRX is a more actively managed with annual turnover of: 32.00 vs. RGEBX (25.00). JLGRX has a lower initial minimum investment than RGEBX: JLGRX (0) vs RGEBX (250). JLGRX annual gain was more profitable for investors over the last year : 22.71 vs. RGEBX (17.59). JLGRX return over 5 years is better than : 59.32 vs. RGEBX (38.71).
JLGRXRGEBXJLGRX / RGEBX
Total Expense Ratio0.541.0950%
Annual Report Gross Expense Ratio0.601.0955%
Fund Existence16 years11 years-
Gain YTD10.95915.39871%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets119B332B36%
Annual Yield % from dividends0.100.00-
Returns for 1 year22.7117.59129%
Returns for 3 years86.5557.61150%
Returns for 5 years59.3238.71153%
Returns for 10 years151.3091.44165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In